Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
about
Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds.Systematic analysis of insertions and deletions specific to nematode proteins and their proposed functional and evolutionary relevance.Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events.Anti-angiogenic peptides for cancer therapeuticsSmall peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formationAntiAngioPred: A Server for Prediction of Anti-Angiogenic PeptidesInhibitory effect of a novel peptide, H-RN, on keratitis induced by LPS or poly(I:C) in vitro and in vivo via suppressing NF-κB and MAPK activation.Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitorsThrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.Peptides derived from histidine and methionine-rich regions of copper transporter 1 exhibit anti-angiogenic property by chelating extracellular Cu.A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.Using a Classifier Fusion Strategy to Identify Anti-angiogenic Peptides
P2860
Q30377821-9760F51F-F56F-4D62-853E-28345D068321Q30493655-AB216783-B072-4189-8379-E9E07E3BF771Q33403657-F664A004-BF43-4591-9808-B99973989308Q33528171-DCEF6AAC-D0EF-4E5C-B990-A36DC3C2AC0EQ33789026-83EF8A53-CA4C-4B06-BAF9-E8AA6B91C3D9Q34208338-1D4A5039-AF46-4BC0-940A-318B88F5AFD0Q34551428-4ABA00B3-3253-4F41-BA78-2CCD3C5B8A30Q34596341-FEA94745-A08B-4C9F-BC36-4DBF5D6B1372Q34808641-BA7C7ED1-E241-431E-8CB1-E881CFF67FA3Q35043016-58701EB3-812B-4E00-89CF-7CB6B369B516Q35501362-BA1A1B9D-54C6-4175-BEE4-B799181A83AAQ35763338-B97F710E-3BFD-41FA-9E71-045605D54C08Q37609648-F53A2105-5BAA-4B64-BC62-479A7BA51B32Q37840948-C74FCC28-127F-4E19-90DD-0568C5CEB3E4Q38974266-C87CD688-94ED-42BC-B156-8350C92378B0Q47405880-89F8DE72-2B18-4478-B791-2E5897094091Q51517581-4A9078D7-793A-40B9-B5CF-64A5326FCAF6Q54482424-4D9525F7-E36D-4A7E-BB56-6D7408C9853AQ58740632-E1A2EB3C-13F7-4C07-94A5-EDB20A5CCEEB
P2860
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@ast
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@en
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@nl
type
label
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@ast
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@en
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@nl
prefLabel
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@ast
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@en
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@nl
P1476
Developing antiangiogenic peptide drugs for angiogenesis-related diseases.
@en
P2093
P304
P356
10.2174/138161207781039715
P577
2007-01-01T00:00:00Z